May 23 (Reuters) - GSK plc:
* GSK: STATEMENT: ZANTAC (RANITIDINE) LITIGATION - VALADEZ AND WILLIAMS CASES
* GSK: JURY IN VALADEZ CASE IN ILLINOIS STATE COURT FINDS GSK NOT LIABLE FOR PLAINTIFF’S COLORECTAL CANCER
* GSK: NEXT ZANTAC TRIAL DUE TO START IN ILLINOIS DISMISSED
* GSK - VERDICT CONSISTENT WITH SCIENTIFIC CONSENSUS THAT THERE IS NO CONSISTENT OR RELIABLE EVIDENCE THAT RANITIDINE INCREASES THE RISK OF ANY CANCER
* GSK: WILL CONTINUE TO "VIGOROUSLY DEFEND" ITSELF AGAINST ALL OTHER CLAIMS Further company coverage: